Accelerate

AXDX NASDAQ
18.29
+0.36
+2.01%
After Hours: 18.29 0 0.00% 17:00 08/16 EDT
Open
18.01
Prev Close
17.93
High
18.51
Low
17.78
Volume
208.76K
Avg Vol (3M)
185.83K
52 Week High
24.75
52 Week Low
10.23
% Turnover
0.38%
Market Cap
997.09M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Accelerate AXDX stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
MORE >

Recently

Name
Price
%Change